CD83 and Behcet disease: The IL-17 level was downregulated in CD83 siRNA-treated BD symptomatic mice (25.2 ± 26.2 pg/mL) compared to that in nontreated BD mice (54.4 ± 35.3 pg/mL) (p = 0.12) (Figure 4).